Covenant Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Covenant Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$299K	Hold	2,343	–	–	0.05%	143
2025 Q4	$286K	Hold	2,343	–	–	0.03%	148
2025 Q3	$235K	Buy	+2,343	New	+$211K	0.03%	154
2025 Q2	–	Sell	-2,559	Closed	-$208K	–	172
2025 Q1	$208K	Sell	2,559 -284	-10%	-$25.4K	0.05%	152
2024 Q4	$256K	Hold	2,843	–	–	0.04%	152
2024 Q3	$281K	Hold	2,843	–	–	0.04%	147
2024 Q2	$264K	Sell	2,843 -400	-12%	-$35.9K	0.04%	145
2024 Q1	$308K	Hold	3,243	–	–	0.05%	123
2023 Q4	$290K	Buy	3,243 +483	+18%	+$35.9K	0.05%	137
2023 Q3	$202K	Hold	2,760	–	–	0.05%	148
2023 Q2	$230K	Hold	2,760	–	–	0.06%	147
2023 Q1	$210K	Hold	2,760	–	–	0.05%	158
2022 Q4	$229K	Hold	2,760	–	–	0.05%	159
2022 Q3	$219K	Hold	2,760	–	–	0.06%	145
2022 Q2	$205K	Hold	2,760	–	–	0.07%	148
2022 Q1	$248K	Hold	2,760	–	–	0.07%	138
2021 Q4	$309K	Sell	2,760 -50	-2%	-$6.03K	0.08%	118
2021 Q3	$353K	Hold	2,810	–	–	0.1%	112
2021 Q2	$380K	Hold	2,810	–	–	0.11%	111
2021 Q1	$381K	Sell	2,810 -15	-0.5%	-$2.25K	0.12%	121
2020 Q4	$398K	Hold	2,825	–	–	0.13%	115
2020 Q3	$315K	Hold	2,825	–	–	0.1%	115
2020 Q2	$316K	Hold	2,825	–	–	0.07%	121
2020 Q1	$219K	Sell	2,825 -820	-22%	-$72.6K	0.07%	132
2019 Q4	$347K	Sell	3,645 -805	-18%	-$69.6K	0.15%	124
2019 Q3	$339K	Hold	4,450	–	–	0.17%	119
2019 Q2	$390K	Sell	4,450 -505	-10%	-$43.1K	0.2%	111
2019 Q1	$449K	Sell	4,955 -27,065	-85%	-$2.3M	0.24%	102
2018 Q4	$3.07M	Hold	32,020	–	–	1.55%	14
2018 Q3	$3.07M	Buy	32,020 +407	+1%	+$39.5K	1.55%	14
2018 Q2	$3.01M	Sell	31,613 -706	-2%	-$64.9K	1.63%	14
2018 Q1	$2.83M	Buy	32,319 +18,771	+139%	+$1.71M	1.64%	12
2017 Q4	$1.15M	Buy	+13,548	New	+$1.13M	0.67%	60

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Covenant Asset Management's XBI Position: Q1 2026 in Review

Covenant Asset Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 2,343 shares worth $299K. The position accounts for 0.05% of the portfolio, ranked #143.

Covenant Asset Management first reported a position in XBI in Q4 2017 and has held it in 33 quarters since. The position peaked at $3.07M in Q4 2018. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Covenant Asset Management held 2,343 shares of State Street SPDR S&P Biotech ETF worth $299K as of Q1 2026.
Covenant Asset Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
State Street SPDR S&P Biotech ETF made up 0.05% of Covenant Asset Management's portfolio in Q1 2026, its #143 holding.
Covenant Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and has held it in 33 quarters since.
Covenant Asset Management's State Street SPDR S&P Biotech ETF position peaked at $3.07M in Q4 2018.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Covenant Asset Management's 13F filing for Q1 2026, filed 14 Apr 2026.